Roche To Meet With Generic Firms On Tamiflu Rights After Intervention From Senators
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche agrees to meet with Teva, Mylan, Ranbaxy and Barr to discuss granting manufacturing rights for Tamiflu in order to meet growing global demand for the avian flu antiviral.